96 related articles for article (PubMed ID: 8687466)
1. Effect of platelet-activating factor on cell differentiation of Trypanosoma cruzi.
Rodrigues CO; Dutra PM; Souto-Padrón T; Cordeiro RS; Lopes AH
Biochem Biophys Res Commun; 1996 Jun; 223(3):735-40. PubMed ID: 8687466
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor induction of secreted phosphatase activity in Trypanosoma cruzi.
Rodrigues CO; Dutra PM; Barros FS; Souto-Padrón T; Meyer-Fernandes JR; Lopes AH
Biochem Biophys Res Commun; 1999 Dec; 266(1):36-42. PubMed ID: 10581161
[TBL] [Abstract][Full Text] [Related]
3. Effects of platelet-activating factor on the interaction of Trypanosoma cruzi with Rhodnius prolixus.
Zimmermann LT; Folly E; Gomes MT; Alviano DS; Alviano CS; Silva-Filho FC; Atella GC; Lopes AH
Parasitol Res; 2011 Jun; 108(6):1473-8. PubMed ID: 21161276
[TBL] [Abstract][Full Text] [Related]
4. Effect of platelet-activating factor on the process of cellular differentiation of Herpetomonas muscarum muscarum.
Lopes AH; Dutra PM; Rodrigues CO; Soares MJ; Angluster J; Cordeiro RS
J Eukaryot Microbiol; 1997; 44(4):321-5. PubMed ID: 9225446
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruzi.
Gazos-Lopes F; Oliveira MM; Hoelz LV; Vieira DP; Marques AF; Nakayasu ES; Gomes MT; Salloum NG; Pascutti PG; Souto-Padrón T; Monteiro RQ; Lopes AH; Almeida IC
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3077. PubMed ID: 25101628
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor (PAF) modulates peritoneal mouse macrophage infection by Leishmania amazonensis.
Rosa MS; Vieira RB; Pereira AF; Dutra PM; Lopes AH
Curr Microbiol; 2001 Jul; 43(1):33-7. PubMed ID: 11375661
[TBL] [Abstract][Full Text] [Related]
7. The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calves.
Bastos da Silva MB; Gustin P; Herion F; Raskinet R; David JL; Gougnard T; Plomteux G; Desmecht D; Lekeux P
Vet Res Commun; 1997 Oct; 21(7):521-31. PubMed ID: 9345719
[TBL] [Abstract][Full Text] [Related]
8. Combined effect of Web 2086 (Paf antagonist) and ketoprofen (Nsaid) on Paf-induced ex vivo platelet aggregation in bovine.
Bastos da Silva M; Herion F; Raskinet R; David JL; Gustin P; Lekeux P
Zentralbl Veterinarmed A; 1997 Apr; 44(2):65-71. PubMed ID: 9284631
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor-like activity isolated from Trypanosoma cruzi.
Gomes MT; Monteiro RQ; Grillo LA; Leite-Lopes F; Stroeder H; Ferreira-Pereira A; Alviano CS; Barreto-Bergter E; Neto HC; Cunha E Silva NL; Almeida IC; Soares RM; Lopes AH
Int J Parasitol; 2006 Feb; 36(2):165-73. PubMed ID: 16337632
[TBL] [Abstract][Full Text] [Related]
10. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
Grigoriadis G; Stewart AG
Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
[TBL] [Abstract][Full Text] [Related]
11. WEB 2086, a platelet-activating factor antagonist, inhibits prophenoloxidase-activating system and hemocyte microaggregation reactions induced by Trypanosoma rangeli infection in Rhodnius prolixus hemolymph.
Machado EM; Azambuja P; Garcia ES
J Insect Physiol; 2006 Jul; 52(7):685-92. PubMed ID: 16777137
[TBL] [Abstract][Full Text] [Related]
12. Human monocytes maintained in culture acquire functional responsiveness to platelet-activating factor that is independent of increases in protein tyrosine phosphorylation.
Grigoriadis G; Stewart AG
Clin Exp Pharmacol Physiol; 1997 Aug; 24(8):563-9. PubMed ID: 9269528
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
14. In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes.
Shimada A; Ota Y; Sugiyama Y; Sato S; Kume K; Shimizu T; Inoue S
J Invest Dermatol; 1998 Jun; 110(6):889-93. PubMed ID: 9620295
[TBL] [Abstract][Full Text] [Related]
15. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
[TBL] [Abstract][Full Text] [Related]
17. The thieno-triazolodiazepine WEB 2086 inhibits platelet aggregation and ATP release from porcine platelets induced by platelet activating factor (PAF).
Griffin KJ; Levy JV
Thromb Res; 1988 Jul; 51(2):219-23. PubMed ID: 3187959
[No Abstract] [Full Text] [Related]
18. Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man.
Hayes JP; Ridge SM; Griffith S; Barnes PJ; Chung KF
J Allergy Clin Immunol; 1991 Jul; 88(1):83-8. PubMed ID: 2071787
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3.
Hostettler ME; Knapp PE; Carlson SL
Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
